1. Home
  2. BHVN vs DLO Comparison

BHVN vs DLO Comparison

Compare BHVN & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • DLO
  • Stock Information
  • Founded
  • BHVN 2013
  • DLO 2013
  • Country
  • BHVN United States
  • DLO Uruguay
  • Employees
  • BHVN N/A
  • DLO N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • DLO Business Services
  • Sector
  • BHVN Health Care
  • DLO Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • DLO Nasdaq
  • Market Cap
  • BHVN 3.6B
  • DLO 3.3B
  • IPO Year
  • BHVN 2017
  • DLO 2021
  • Fundamental
  • Price
  • BHVN $39.17
  • DLO $12.02
  • Analyst Decision
  • BHVN Strong Buy
  • DLO Hold
  • Analyst Count
  • BHVN 13
  • DLO 10
  • Target Price
  • BHVN $63.00
  • DLO $12.45
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • DLO 1.0M
  • Earning Date
  • BHVN 02-27-2025
  • DLO 03-17-2025
  • Dividend Yield
  • BHVN N/A
  • DLO N/A
  • EPS Growth
  • BHVN N/A
  • DLO N/A
  • EPS
  • BHVN N/A
  • DLO 0.40
  • Revenue
  • BHVN N/A
  • DLO $729,488,000.00
  • Revenue This Year
  • BHVN N/A
  • DLO $15.98
  • Revenue Next Year
  • BHVN $197.13
  • DLO $25.99
  • P/E Ratio
  • BHVN N/A
  • DLO $29.50
  • Revenue Growth
  • BHVN N/A
  • DLO 25.61
  • 52 Week Low
  • BHVN $26.80
  • DLO $6.58
  • 52 Week High
  • BHVN $62.21
  • DLO $18.27
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.03
  • DLO 60.66
  • Support Level
  • BHVN $35.01
  • DLO $11.55
  • Resistance Level
  • BHVN $39.36
  • DLO $11.94
  • Average True Range (ATR)
  • BHVN 2.07
  • DLO 0.37
  • MACD
  • BHVN 0.50
  • DLO 0.01
  • Stochastic Oscillator
  • BHVN 77.83
  • DLO 89.90

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables global enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.

Share on Social Networks: